Verastem Oncology (VSTM) – Analyst EPS Change
-
Verastem (VSTM) PT Cut To $10 At HCWainwright After Copiktra Underperformance
-
Verastem (VSTM) PT Raised to $6.50 at H.C. Wainwright; 'Duvelisib has Significant Commercial Potential'
-
Back to VSTM Stock Lookup